Resource Library

Brochure: Trusted Solutions for Medical Device Manufacturers

United States

GORE^® Microfiltration Media for Medical Devices delivers superior performance to the medical industry in applications for non-implantable medical devices and is the material of choice when performance is critical.

View as PDF (15 MB)

Contact Us

Americas

+1 800 294 4673

+1 410 506 1715

Europe

+49 89 4612 3456

+800 4612 3456

All Other Inquiries

+1 800 294 4673

+1 410 506 1715

Contact by email

Medical News & Events

Press Release

Physicians in the U.S. Begin Commercial Use of the GORE^® Excluder^® Conformable AAA Endoprosthesis With Active Control System

Posted March 29, 2021

Today, W. L. Gore & Associates, Inc. (Gore) announces the first use of the FDA approved GORE® EXCLUDER® Conformable AAA Endoprothesis with ACTIVE CONTROL System in cases outside of clinical trials. Cases were successfully performed by Robert Rhee, M.D. with Mahmoud Almadani, M.D., in Brooklyn, New York and by Gustavo Oderich, M.D. with Naveed Saqib, M.D., in Houston, Texas.

Press Release

W. L. Gore & Associates Announces Encouraging Six-month Results with Its Novel Biosynthetic Tissue Valve

Posted November 18, 2020

W. L. Gore & Associates, Inc. (Gore), a global leader in providing solutions for cardiovascular disease, today announced encouraging clinical results from its early feasibility study evaluating the safety and performance of its pulmonary valved conduit, an investigational device.

Press Release

Gore Receives CE Mark for the GORE® CARDIOFORM ASD Occluder for the Treatment of Atrial Septal Defects in Europe

Posted October 2, 2019

W. L. Gore & Associates has introduced the newest member of its family of occluders, the GORE® CARDIOFORM ASD Occluder, which has received CE Mark. The device offers physicians a clinically proven design in a device that, in a recent study, met its primary endpoint for the percutaneous, transcatheter closure of ostium secundum atrial defects (ASDs).